Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
0
0
FDA says Novo Nordisk's TV ad for obesity pill includes 'false or misleading' claims - CNBC
2/9/26 at 5:04pm
Organization
CNBC
Author
Annika Kim Constantino
40 words
0
Comments
The FDA requested that Novo take immediate action to address the violations, which could include ceasing all ads containing misleading claims about the pill.
Business & Industrial
Drugs & Medications
Pharmaceuticals & Biotech
Obesity
Health News
Weight Loss
TV Commercials
Consumer Advocacy & Protection
Company News
You are the first to view
https://www.cnbc.com/2026/02/09/fda-novo-nordisk-wegovy-tv-ad.html
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...